title: N-methyl-D-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide.
abstract: N-methyl-D-aspartate receptors, found throughout the mammalian brain, are a component of the major excitatory transmitter system. Strong evidence exists that N-methyl-D-aspartate receptors, by promoting excessive entry of Ca2+ into neurons, play a role in neuronal damage that follows head injury, strokes, and epileptic seizures, and is associated with degenerative diseases such as Alzheimer's disease. Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. We have investigated whether N-methyl-D-aspartate receptors exist in peripheral neurons, and, if so, whether their activation may result in tissue injury. We report that N-methyl-D-aspartate receptors exist in the lung, that their activation triggers acute injury, and that, as in toxicity to central neurons, this injury is associated with stimulation of nitric oxide synthesis, and can be attenuated by inhibition of this synthesis. Finally, vasoactive intestinal peptide, which protects the lung and heart against oxidant injury and promotes neuronal survival and differentiation also prevented N-methyl-D-aspartate lung injury, apparently by inhibiting a key neurotoxic action of nitric oxide, but not its production. The findings suggest that N-methyl-D-aspartate receptors exist in the peripheral nervous system and that activation of these receptors, resulting in damage to peripheral neurons, may be a novel mechanism of lung and other organ injury.
authors.affiliation: Department of Medicine, University Medical Center, Stony Brook, New York, USA.
authors.forename: S I
authors.initials: SI
authors.lastname: Said
authors.forename: H I
authors.initials: HI
authors.lastname: Berisha
authors.forename: H
authors.initials: H
authors.lastname: Pakbaz
mesh_terms: D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism; D008171:Lung Diseases / Q000139:chemically induced / Q000378:metabolism*; D016202:N-Methylaspartate / Q000494:pharmacology; D009569:Nitric Oxide / Q000096:biosynthesis*; D009929:Organ Size / Q000187:drug effects; D017933:Peripheral Nervous System / Q000187:drug effects / Q000293:injuries / Q000378:metabolism*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate; D009569:Nitric Oxide; D014660:Vasoactive Intestinal Peptide; D016202:N-Methylaspartate; D015763:2-Amino-5-phosphonovalerate; D006152:Cyclic GMP